ALEC vs SABS: stock comparison and AI forecast
Alector, Inc. (ALEC) and Sab Biotherapeutics, Inc. (SABS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALEC Alector, Inc.
- Market Cap
- $319M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SABS Sab Biotherapeutics, Inc.
- Market Cap
- $300M
- P/E Ratio
- 165.0x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ALEC and SABS have similar market capitalizations ($319M and $300M).
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALEC | SABS |
|---|---|---|
| Market Cap | $319M | $300M |
| P/E Ratio | – | 165.00x |
| P/B Ratio | – | 1.40x |
| EPS | $-1.30 | $0.02 |
| Book Value/Share | – | $2.36 |
| Revenue/Share | $0.09 | – |
| FCF/Share | $-1.07 | – |
Profitability & Margins
| Metric | ALEC | SABS |
|---|---|---|
| ROA | -58.1% | – |
| ROIC | -75.0% | -31.7% |
| Operating Margin | -986.9% | 6571.2% |
| Net Margin | -919.5% | – |
| EBT Margin | -917.0% | 878.0% |
| Tax Rate | -0.2% | – |
Financial Health
| Metric | ALEC | SABS |
|---|---|---|
| Current Ratio | 5.26x | 9.22x |
| D/E Ratio | – | 0.11x |
| Financial Leverage | – | 1.11x |
| Interest Coverage | -120.2x | -377.0x |
| Working Capital | $146M | $96M |
Cash Flow
| Metric | ALEC | SABS |
|---|---|---|
| Operating Cash Flow | -$158M | -$54M |
| Free Cash Flow | -$158M | – |
| Capital Spending | -$160K | – |
| FCF/Sales | -1235.8% | – |
| CapEx/Sales | 1.2% | – |
Operational Efficiency
| Metric | ALEC | SABS |
|---|---|---|
| Asset Turnover | 0.06x | – |
| Fixed Assets Turnover | 1.4x | – |
Income Statement
| Metric | ALEC | SABS |
|---|---|---|
| Total Revenue | $13M | – |
| Operating Income | -$126M | -$72M |
| Net Income | -$118M | – |
| R&D Expense | $99M | $49M |
Dividend & Shareholder Information
| Metric | ALEC | SABS |
|---|---|---|
| Shares Outstanding | 148M | 91M |
ALEC vs SABS: stock comparison and AI forecast
Which is bigger, ALEC or SABS?
ALEC and SABS have similar market capitalizations ($319M and $300M).
Which one does Intratio's AI model rank higher, ALEC or SABS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.